AFYX Therapeutics
  • Reversed Innovation
  • Our Products
  • Conferences
  • News
  • Management
  • About Us
Select Page
Cevidra SAS and AFYX Therapeutics A/S announce distribution and collaboration agreement for France

Cevidra SAS and AFYX Therapeutics A/S announce distribution and collaboration agreement for France

PRESS RELEASE Cevidra SAS and AFYX Therapeutics A/S announce distribution and collaboration agreement for France. Hørsholm, Denmark January 13th 2025 – AFYX Therapeutics A/S and Cevidra SAS are pleased to announce a strategic partnership aimed at bringing...
Cevidra SAS and AFYX Therapeutics A/S announce distribution and collaboration agreement for France

Er-Kim and AFYX Therapeutics A/S announce distribution and sales collaboration

PRESS RELEASE Hørsholm, Denmark – 6th January 2025 Er-Kim and AFYX Therapeutics A/S announced today a distribution and sales collaboration for two AFYX products. The two companies have entered a mutual sales and distribution collaboration where Er-Kim will sell and...
Cevidra SAS and AFYX Therapeutics A/S announce distribution and collaboration agreement for France

Danish biopharmaceutical leader AFYX Therapeutics A/S secures DKK 25 million in Funding

Danish Biopharmaceutical Leader AFYX Therapeutics A/S Secures DKK 25 million in Funding to Drive Product Development and Global Expansion. PRESS RELEASE Copenhagen, Denmark – December 19, 2025 AFYX Therapeutics A/S, a pioneering Danish biopharmaceutical company...
Next Entries »